SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2y05'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EKJ_F_ACTF3008_0
(BETA-CARBONIC
ANHYDRASE)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 8 ASP A 212
VAL A 139
GLY A 142
GLY A 141
 None
 0.63A 1ekjE-2y05A:
undetectable
1ekjF-2y05A:
undetectable		 1ekjE-2y05A:
20.97
1ekjF-2y05A:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FE2_A_LAXA700_2
(PROSTAGLANDIN
ENDOPEROXIDE H
SYNTHASE-1)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		5 / 12 TYR A 181
GLY A 152
ALA A 153
SER A 156
GLY A 159
 None
NAP  A 701 (-3.1A)
NAP  A 701 (-3.3A)
None
None
 0.98A 1fe2A-2y05A:
undetectable		 1fe2A-2y05A:
20.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IGX_A_EPAA700_1
(PROSTAGLANDIN
ENDOPEROXIDE H
SYNTHASE-1)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		5 / 12 TYR A 181
GLY A 152
ALA A 153
SER A 156
GLY A 159
 None
NAP  A 701 (-3.1A)
NAP  A 701 (-3.3A)
None
None
 0.97A 1igxA-2y05A:
undetectable		 1igxA-2y05A:
20.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NHZ_A_486A800_1
(GLUCOCORTICOID
RECEPTOR)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		5 / 12 LEU A 322
ASN A 321
GLY A 152
VAL A 154
LEU A 185
 None
NAP  A 701 (-3.1A)
NAP  A 701 (-3.1A)
NAP  A 701 (-3.7A)
None
 1.29A 1nhzA-2y05A:
undetectable		 1nhzA-2y05A:
22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_B_SAMB802_0
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		5 / 12 ALA A 153
GLY A 123
GLY A 120
LEU A 284
LEU A 127
 NAP  A 701 (-3.3A)
None
None
None
EDO  A1332 (-3.9A)
 1.07A 1rjdB-2y05A:
5.8		 1rjdB-2y05A:
20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_A_CLMA1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 7 PRO A 252
GLY A 254
PRO A 255
ILE A 227
 None
 0.71A 1usqA-2y05A:
undetectable		 1usqA-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_B_CLMB1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 6 PRO A 252
GLY A 254
PRO A 255
ILE A 227
 None
 0.69A 1usqB-2y05A:
undetectable		 1usqB-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_C_CLMC1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 6 PRO A 252
GLY A 254
PRO A 255
ILE A 227
 None
 0.70A 1usqC-2y05A:
undetectable		 1usqC-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_D_CLMD1142_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 6 PRO A 252
GLY A 254
PRO A 255
ILE A 227
 None
 0.70A 1usqD-2y05A:
undetectable		 1usqD-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_E_CLME1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 6 PRO A 252
GLY A 254
PRO A 255
ILE A 227
 None
 0.72A 1usqE-2y05A:
undetectable		 1usqE-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_F_CLMF1144_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 7 PRO A 252
GLY A 254
PRO A 255
ILE A 227
 None
 0.70A 1usqF-2y05A:
undetectable		 1usqF-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1VPT_A_SAMA400_0
(VP39)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		5 / 12 LEU A 182
ILE A 161
GLY A 171
VAL A 157
LEU A 287
 None
 1.06A 1vptA-2y05A:
5.5		 1vptA-2y05A:
23.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EJ3_C_GBNC1414_1
(BRANCHED-CHAIN AMINO
ACID
AMINOTRANSFERASE)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		5 / 8 TYR A 181
GLY A 159
GLY A 155
ALA A 151
ALA A 150
 None
 1.38A 2ej3C-2y05A:
undetectable		 2ej3C-2y05A:
23.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKJ_A_CLMA1141_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 6 PRO A 252
GLY A 254
PRO A 255
ILE A 227
 None
 0.71A 2jkjA-2y05A:
undetectable		 2jkjA-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKJ_B_CLMB1141_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 6 PRO A 252
GLY A 254
PRO A 255
ILE A 227
 None
 0.70A 2jkjB-2y05A:
undetectable		 2jkjB-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKJ_C_CLMC1141_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 6 PRO A 252
GLY A 254
PRO A 255
ILE A 227
 None
 0.70A 2jkjC-2y05A:
undetectable		 2jkjC-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKJ_E_CLME1141_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 7 PRO A 252
GLY A 254
PRO A 255
ILE A 227
 None
 0.70A 2jkjE-2y05A:
undetectable		 2jkjE-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_A_CLMA1144_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 7 PRO A 252
GLY A 254
PRO A 255
ILE A 227
 None
 0.67A 2jklA-2y05A:
undetectable		 2jklA-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_B_CLMB1144_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 6 PRO A 252
GLY A 254
PRO A 255
ILE A 227
 None
 0.68A 2jklB-2y05A:
undetectable		 2jklB-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_C_CLMC1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 7 PRO A 252
GLY A 254
PRO A 255
ILE A 227
 None
 0.67A 2jklC-2y05A:
undetectable		 2jklC-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_D_CLMD1145_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 7 PRO A 252
GLY A 254
PRO A 255
ILE A 227
 None
 0.68A 2jklD-2y05A:
undetectable		 2jklD-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_E_CLME1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 7 PRO A 252
GLY A 254
PRO A 255
ILE A 227
 None
 0.69A 2jklE-2y05A:
undetectable		 2jklE-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_F_CLMF1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 7 PRO A 252
GLY A 254
PRO A 255
ILE A 227
 None
 0.68A 2jklF-2y05A:
undetectable		 2jklF-2y05A:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OAX_C_SNLC3001_1
(MINERALOCORTICOID
RECEPTOR)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		5 / 12 ASN A 217
ALA A 149
LEU A 317
THR A 128
PHE A 215
 NAP  A 701 (-3.8A)
NAP  A 701 ( 3.9A)
None
NAP  A 701 (-3.1A)
None
 1.37A 2oaxC-2y05A:
undetectable		 2oaxC-2y05A:
20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OAX_F_SNLF6001_1
(MINERALOCORTICOID
RECEPTOR)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		5 / 12 ASN A 217
ALA A 149
LEU A 317
THR A 128
PHE A 215
 NAP  A 701 (-3.8A)
NAP  A 701 ( 3.9A)
None
NAP  A 701 (-3.1A)
None
 1.34A 2oaxF-2y05A:
undetectable		 2oaxF-2y05A:
20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QD5_A_CHDA701_0
(FERROCHELATASE)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 8 MET A 146
LEU A 203
VAL A 218
GLY A 219
 None
None
NAP  A 701 (-4.3A)
None
 1.06A 2qd5A-2y05A:
2.8		 2qd5A-2y05A:
21.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2WEK_B_DIFB1376_1
(ZINC-BINDING ALCOHOL
DEHYDROGENASE
DOMAIN-CONTAINING
PROTEIN 2)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 7 TYR A 193
VAL A 218
GLY A 220
SER A 243
 NAP  A 701 (-4.2A)
NAP  A 701 (-4.3A)
None
NAP  A 701 (-4.9A)
 0.49A 2wekB-2y05A:
35.7		 2wekB-2y05A:
30.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3B_A_RBFA191_1
(LUMAZINE PROTEIN)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		5 / 12 VAL A  46
LEU A  44
THR A  45
ALA A 329
ASN A 308
 None
 1.18A 3a3bA-2y05A:
undetectable		 3a3bA-2y05A:
20.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BJW_C_SVRC507_2
(PHOSPHOLIPASE A2)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 6 VAL A 169
VAL A 170
GLN A 229
PHE A 215
 None
 1.22A 3bjwF-2y05A:
undetectable		 3bjwF-2y05A:
16.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BJW_G_SVRG506_2
(PHOSPHOLIPASE A2)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 5 VAL A 169
VAL A 170
GLN A 229
PHE A 215
 None
 1.35A 3bjwB-2y05A:
undetectable		 3bjwB-2y05A:
16.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KKZ_B_SAMB302_0
(UNCHARACTERIZED
PROTEIN Q5LES9)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		5 / 12 GLY A 323
GLY A 319
LEU A 317
SER A 243
ALA A 149
 None
NAP  A 701 (-3.4A)
None
NAP  A 701 (-4.9A)
NAP  A 701 ( 3.9A)
 1.03A 3kkzB-2y05A:
6.5		 3kkzB-2y05A:
20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VHU_A_SNLA1001_1
(MINERALOCORTICOID
RECEPTOR)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		5 / 12 ASN A 217
ALA A 149
LEU A 317
THR A 128
PHE A 215
 NAP  A 701 (-3.8A)
NAP  A 701 ( 3.9A)
None
NAP  A 701 (-3.1A)
None
 1.35A 3vhuA-2y05A:
undetectable		 3vhuA-2y05A:
20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4J24_C_ESTC600_1
(ESTROGEN RECEPTOR
BETA)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		5 / 12 LEU A  86
GLU A 103
LEU A 284
ARG A 280
ILE A 113
 None
None
None
EDO  A1332 (-4.3A)
None
 1.31A 4j24C-2y05A:
undetectable		 4j24C-2y05A:
22.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JTR_A_IBPA401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 8 TYR A 214
VAL A 218
LEU A 203
LEU A 199
 None
NAP  A 701 (-4.3A)
None
None
 1.07A 4jtrA-2y05A:
undetectable		 4jtrA-2y05A:
22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OBW_A_SAMA602_0
(2-METHOXY-6-POLYPREN
YL-1,4-BENZOQUINOL
METHYLASE,
MITOCHONDRIAL)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		5 / 12 TYR A 214
ALA A 172
GLY A 171
ASN A 217
GLY A 174
 None
None
None
NAP  A 701 (-3.8A)
NAP  A 701 (-3.3A)
 0.99A 4obwA-2y05A:
7.9		 4obwA-2y05A:
25.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OBW_B_SAMB601_0
(2-METHOXY-6-POLYPREN
YL-1,4-BENZOQUINOL
METHYLASE,
MITOCHONDRIAL)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		5 / 12 TYR A 214
ALA A 172
GLY A 171
ASN A 217
GLY A 174
 None
None
None
NAP  A 701 (-3.8A)
NAP  A 701 (-3.3A)
 1.02A 4obwB-2y05A:
7.7		 4obwB-2y05A:
25.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OBW_D_SAMD601_0
(2-METHOXY-6-POLYPREN
YL-1,4-BENZOQUINOL
METHYLASE,
MITOCHONDRIAL)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		5 / 12 TYR A 214
ALA A 172
GLY A 171
ASN A 217
GLY A 174
 None
None
None
NAP  A 701 (-3.8A)
NAP  A 701 (-3.3A)
 0.97A 4obwD-2y05A:
7.3		 4obwD-2y05A:
25.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ESL_A_1YNA701_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		5 / 12 GLY A  60
ILE A 242
TYR A 245
THR A  45
THR A   8
 None
NAP  A 701 (-3.8A)
NAP  A 701 (-4.6A)
None
None
 1.09A 5eslA-2y05A:
undetectable		 5eslA-2y05A:
20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MVS_A_ADNA401_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 7 GLY A 171
ALA A 206
ASP A 188
ASN A 148
 None
 0.97A 5mvsA-2y05A:
6.6		 5mvsA-2y05A:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MVS_B_ADNB401_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 8 GLY A 171
ALA A 206
ASP A 188
ASN A 148
 None
 0.96A 5mvsB-2y05A:
6.4		 5mvsB-2y05A:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TUD_D_ERMD1201_2
(5-HYDROXYTRYPTAMINE
RECEPTOR 2B,SOLUBLE
CYTOCHROME B562
CHIMERA)		 2y05 PROSTAGLANDIN
REDUCTASE 1
(Homo
sapiens) 		4 / 6 LEU A  38
VAL A  71
THR A  83
LEU A  32
 None
 0.94A 5tudD-2y05A:
undetectable		 5tudD-2y05A:
20.56